Imodium and Klor-con m20 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Klor-con m20 (potassium chloride). Common drug interactions include asthenia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Klor-con m20. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Klor-con m20?

Klor-con m20 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 2,411 Klor-con m20 users. Check the latest studies of Klor-con m20.

On Jul, 12, 2026

63 people who take Imodium and Klor-con m20 together, and have interactions are studied.

Imodium and Klor-con m20 drug interactions.

What are the common drug interactions of Imodium and Klor-Con M20, by gender? *:

female:

Asthenia (weakness)
Bladder disorder
Blood glucose decreased
Blood magnesium decreased
Blood potassium decreased
Botulism (food poisoning caused by botulinum growing)
Chest pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Compression fracture (fracture due to pressure caused by injury)

male:

Fatigue (feeling of tiredness)
Asthenia (weakness)
Death
Hypotension (abnormally low blood pressure)
Infusion related reaction
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Pruritus (severe itching of the skin)
Anaemia (lack of blood)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

What are the common drug interactions of Imodium and Klor-Con M20, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Infection
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
Sepsis (a severe blood infection that can lead to organ failure and death)

30-39:

n/a

40-49:

Abdominal hernia
Anxiety
Cholecystitis chronic (long lasting infection of gallbladder)
Constipation
Emotional distress
Gallbladder disorder
Injection site bruising
Injection site induration
Injury
Nephrolithiasis (calculi in the kidneys)

50-59:

Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Diplopia (double vision)
Drug hypersensitivity
Dysarthria (speech disorder)
Eructation (release of gas from the digestive tract)
Eyelid ptosis (falling of the upper or lower eyelid)
Fatigue (feeling of tiredness)
Food allergy
Gait disturbance
Heart rate decreased

60+:

Fatigue (feeling of tiredness)
Asthenia (weakness)
Back pain
Neutropenia (an abnormally low number of neutrophils)
Rash
White blood cell count decreased
Ageusia (loss of taste functions of the tongue)
Blood creatinine increased
Cough
Gastrointestinal disorder (functional problems of gastrointestinal tract)

What are the existing conditions these people have? *

Pain: 17 people, 26.98%
Nausea (feeling of having an urge to vomit): 10 people, 15.87%
Multiple Myeloma (cancer of the plasma cells): 10 people, 15.87%
Stress And Anxiety: 9 people, 14.29%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 12.70%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 9.52%
Nausea And Vomiting: 5 people, 7.94%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 5 people, 7.94%
High Blood Pressure: 5 people, 7.94%
Dyspnea (difficult or laboured breathing): 5 people, 7.94%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Klor-con m20?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously